Trial Types (Phase I–IV, BE, Observational, RWE)
Pharmaxi MRM Inc.supports a comprehensive range of clinical trial types across the full drug development lifecycle. Our services include Phase I–IV clinical trials, ranging from first-in-human studies and early safety assessments to large-scale confirmatory and post-marketing studies. We also conduct bioequivalence (BE) and bioavailability studies for generic and reformulated products, supported by specialized clinical units and analytical capabilities. In addition, Pharmaxi MRM Inc.manages observational studies and real-world evidence (RWE) programs, enabling sponsors to evaluate treatment outcomes, safety profiles, and healthcare utilization in real clinical settings. Our flexible operational model ensures regulatory compliance, reliable data generation, and efficient study execution across diverse trial designs and therapeutic areas.
Pharmaxi MRM Inc.provides strong site and patient access capabilities through established clinical networks in Eastern Europe, Central Asia, and selected international locations, enabling efficient recruitment and high-quality trial execution. Leveraging Pharmaxi’s long-standing presence and relationships with leading hospitals, investigators, and research institutions, we help sponsors rapidly identify qualified study sites and access diverse patient populations. Our team manages feasibility assessments, site qualification, and patient recruitment strategies tailored to each study’s therapeutic area and protocol requirements. Region-specific operational expertise, combined with local regulatory knowledge and multilingual clinical teams, allows Pharmaxi MRM Inc.to accelerate enrollment timelines while maintaining strict compliance with ICH-GCP and local regulatory standards.
Site & Patient Access (region-specific options)
Technology & Systems (EDC/CTMS/eTMF — “platform-agnostic”)
Pharmaxi MRM Inc.utilizes modern clinical trial technology platforms to ensure efficient data capture, trial oversight, and regulatory compliance across all studies. Our operations integrate industry-standard systems including Electronic Data Capture (EDC), Clinical Trial Management Systems (CTMS), and electronic Trial Master File (eTMF) solutions. The company follows a platform-agnostic approach, allowing sponsors to use their preferred systems or leverage validated partner platforms when needed. Our teams support system setup, configuration, user training, data integration, and quality control to ensure reliable trial management and secure data handling. This flexible digital infrastructure enables real-time study oversight, improved collaboration among stakeholders, and full compliance with FDA 21 CFR Part 11 and ICH-GCP requirements.
